Explore the vast range of titles available.

This paper investigates whether patent applicants strategically withhold citations to material prior art. Citation data suggest that applicants withhold between 21% and 33% of relevant citations. Variation in withholdings is explained by patent portfolio size and indicators of patent value. These data also highlight important differences across technology classes. In particular, firms are significantly less likely to withhold a citation when applying for chemical and drug patents. Robustness checks confirm that these results are not explained by inventor and attorney familiarity with citations, patent examiner heterogeneity, or the nationality of the inventor.

Nanotechnology patent applications published during 1991–2008 have been examined using the “title–abstract” keyword search on esp@cenet “worldwide” database. The longitudinal evolution of the number of patent applications, their topics, and their respective patent families have been evaluated for 15 national patent offices covering 98% of the total global activity. The patent offices of the United States (USA), People’s Republic of China (PRC), Japan, and South Korea have published the largest number of nanotechnology patent applications, and experienced significant but different growth rates after 2000. In most repositories, the largest numbers of nanotechnology patent applications originated from their own countries/regions, indicating a significant “home advantage.” The top applicant institutions are from different sectors in different countries (e.g., from industry in the US and Canada patent offices, and from academe or government agencies at the PRC office). As compared to 2000, the year before the establishment of the US National Nanotechnology Initiative (NNI), numerous new invention topics appeared in 2008, in all 15 patent repositories. This is more pronounced in the USA and PRC. Patent families have increased among the 15 patent offices, particularly after 2005. Overlapping patent applications increased from none in 1991 to about 4% in 2000 and to about 27% in 2008. The largest share of equivalent nanotechnology patent applications (1,258) between two repositories was identified between the US and Japan patent offices.

NRC publication: Yes

This paper analyzes the temporal and spatial characteristics of green invention patent applications during 1985–2018. The results show that China’s green invention patent applications present five stages of slow development, slow growth, accelerating growth, rapid growth and booming. Green invention patent applications in the fields of energy conservation, alternative energy production and waste management have always been in the forefront, but there are relatively less green invention patent applications in transportation and nuclear power; which need to be further strengthened. Green invention patent applications show a high level of geographical agglomeration in space, mainly concentrated in the eastern region, followed by the central region, the western region and northeast region. During the study period, the differences among the four major regions, eastern, northeastern, central and western, showed a trend of first expanding and then narrowing, and the intra-regional differences were the main source of spatial differences. The number of green invention patent applications in the four regions also shifted in space during the research period. The temporal and spatial evolution characteristics are correlative to national and regional innovation policies. Aiming at solving the problems of unbalanced development in different categories of green invention patent applications and regions, this paper puts forward corresponding policy suggestions.

Modern toothpastes are complex formulations with various ingredients. The aim of this study was to analyze the improvement of toothpaste formulations from 1900 to 2023 focusing on active ingredients with remineralizing, antibacterial, or plaque-removing effects, and to discuss their influence on caries prevention. For this, worldwide patent applications were searched using the international database Espacenet from the European Patent Office. Additionally, toothpaste products were searched using the Mintel product database from 1996 to 2023. The searched ingredients were (in alphabetical order): calcium carbonate, calcium phosphates, hydrated silica, sodium fluoride, sodium lauryl sulfate, triclosan, xylitol, and zinc salts as they are known from the scientific literature to be remineralizing or antibacterial/antiplaque agents. It was shown that the number of patent applications containing these ingredients significantly increased since the 1970s. As these ingredients have remineralizing, antibacterial, or plaque-removing effects, they all can contribute to caries prevention. In conclusion, and within the limitations of this approach, this study shows that toothpaste formulations have greatly improved over the past decades by using various active anticaries ingredients.

The United States patent system has become sand rather than lubricant in the wheels of American progress. Such is the premise behind this provocative and timely book by two of the nation's leading experts on patents and economic innovation.

The Japanese Patent Applications filed on the topic of nickel/metal hydride (Ni/MH) batteries have been reviewed. Patent applications filed by the top nine battery manufacturers (Matsushita, Sanyo, Hitachi Maxell, Yuasa, Toshiba, FDK, Furukawa, Japan Storage, and Shin-kobe), five component suppliers (Tanaka, Mitsui, Santoku, Japan Metals & Chemicals Co. (JMC), and Shin-Etsu), and three research institutes (Industrial Research Institute (ISI), Agency of Industrial Science and Technology (AIST), and Toyota R & D) were chosen as the main subjects for this review, based on their production volume and contribution to the field. By reviewing these patent applications, we can have a clear picture of the technology development in the Japanese battery industry. These patent applications also provide insights, know-how, and future directions for engineers and scientists working in the rechargeable battery field.

According to World Intellectual Property Indicators 2014, growth rate of measurement technique was the leader of the top five fields of technology. Professional tool-ISI Web of Knowledge System Derwent World Patents Index database (DWPI) was used to acquire and study patent data. Thomson's patent analyses software TDA was used in measurement technology patents map analysis, paying attention to the technical focus and hot spots. In this paper, searching patent status of measurement from 2010 to 2014 by using professional tool DWPI and TDA, hot spots of patent application in measurement field were found. Considering multi parameters, such as patent application year, patent application country/region and measurement subdivisions, the development trends and hot spots of world patents of measurement analyzed, several proposals were put forward to improve the quality of China measurement patents.

Patent application trends were investigated for induced pluripotent stem cell (iPSC) technologies, particularly disease-specific cell technologies related to iPSCs, in the U.S., Japanese, and European applications during 2017. The number of patent applications for iPSC technologies was 1516 in the United States, 895 in Japan, and 420 in Europe, with 5% of applications for disease-specific cell technologies. In contrast, the percentages of patent applications for iPSC preparation and differentiation technologies were 17% and 23%, respectively. Patent applications for disease-specific cell technologies were classified into four technical fields and 14 disorder groups. In the technical fields, patent applications for genetically engineered cell technologies were prominent, accounting for 63%, 50%, and 65% of the U.S., Japanese, and European applications for 11, 8, and 7 disorder groups, respectively. In the disorder groups, the percentages of patent applications for neurological disorders were 40%, 32%, and 40% of the U.S., Japanese, and European applications, respectively, which were filed in four technical fields in the U.S. and Japanese applications. The U.S. patent applications for disease-specific cell technologies were filed by applicants in the United States, Japan, France, Belgium, Italy, Korea, and Canada; however, patent applications filed by those in Belgium, Italy, and Canada were not found in the Japanese and European applications. The percentages of patent applications filed by the U.S. applicants were 72%, 55%, and 65% of the U.S., Japanese, and European applications, respectively. Most patent applications filed by the U.S. applicants were in the field of genetically engineered cells for 11 disorder groups, which mostly included neurological and blood disorders. Japanese applicants mainly filed patent applications for drug screening technologies; subjects included five disorder groups, particularly neurological and bone/articular disorders. French applicants filed patent applications for neurological disorders in the field of genetically engineered cells and drug screening technologies. Korean applicants filed patent applications for patient-derived cell technologies for neurological, metabolic, and chromosomal/genetic disorders. In conclusion, more than half of patent applications were for genetically engineered cells for 11 disorders, most of which were filed by U.S. applicants.

Theories of innovation emphasize the role of social networks and teams as facilitators of breakthrough discoveries 1 – 4 . Around the world, scientists and inventors are more plentiful and interconnected today than ever before 4 . However, although there are more people making discoveries, and more ideas that can be reconfigured in new ways, research suggests that new ideas are getting harder to find 5 , 6 —contradicting recombinant growth theory 7 , 8 . Here we shed light on this apparent puzzle. Analysing 20 million research articles and 4 million patent applications from across the globe over the past half-century, we begin by documenting the rise of remote collaboration across cities, underlining the growing interconnectedness of scientists and inventors globally. We further show that across all fields, periods and team sizes, researchers in these remote teams are consistently less likely to make breakthrough discoveries relative to their on-site counterparts. Creating a dataset that allows us to explore the division of labour in knowledge production within teams and across space, we find that among distributed team members, collaboration centres on late-stage, technical tasks involving more codified knowledge. Yet they are less likely to join forces in conceptual tasks—such as conceiving new ideas and designing research—when knowledge is tacit 9 . We conclude that despite striking improvements in digital technology in recent years, remote teams are less likely to integrate the knowledge of their members to produce new, disruptive ideas. Analysis of research articles and patent applications shows that members of teams that collaborate remotely are less likely to make breakthrough discoveries than members of on-site teams.